Acute psychosocial stress may act as a hidden accelerator of opioid reinforcement, according to a new randomized laboratory study in Nature Mental Health. The work tests a central concern in opioid risk: patients and healthy individuals often receive opioid analgesics during stressful events such as trauma or surgery, yet the mechanisms linking stress to later misuse remain incompletely understood.
Researchers recruited 85 healthy volunteers with limited prior opioid exposure and used a triple-blind, block-randomized, placebo- and state-induction controlled, four-way crossover design. Participants underwent either a laboratory social stress induction or a neutral control state, after which they received an intravenous sampling dose of oxycodone (3 mg per 70 kg) or saline. This repeated, within-person structure aimed to isolate the effects of stress state, opioid exposure, and placebo conditions while reducing individual variability.
Across 257 eligible sessions from 66 participants, oxycodone produced a typical drug high without improving mood ratings or alleviating the induced stress relative to placebo. Expected opioid side effects were observed, and critically, no serious adverse events occurred—supporting the feasibility of studying opioid reinforcement under tightly controlled conditions in healthy adults.
The primary endpoints combined pharmacological experience with behavioral choice: participants reported drug desire and performed an effortful task intended to index opioid self-administration. To quantify stress effects, the team applied hierarchical ordinal Bayesian regression models, a framework well suited to ordered outcomes and uncertain parameters.
The analysis indicated that stress credibly increased oxycodone self-administration by an absolute 6 percentage points (95% credible interval 1 to 10), with posterior probability exceeding 0.99. A striking sex-specific pattern emerged: the effect was driven by men, with a robust 19 percentage-point difference (95% credible interval 10 to 28; posterior probability >0.99). In contrast, stress-enhanced opioid self-administration was not observed in the women tested.
Notably, the stress-driven increase in men was not tied to improved subjective drug effects or stress relief, suggesting that stress may increase opioid reinforcement through pathways beyond immediate affective comfort. Together, the results align with heightened risk for persistent opioid use following exposure under high psychosocial stress.
The trial is registered at ClinicalTrials.gov (NCT06485817) and was funded by the European Research Council (grant no. 802885) and the Swedish Research Council (grant no. 2013-07434).
Subject of Research: Psychosocial stress and opioid reinforcement
Article Title: Effects of psychosocial stress on opioid self-administration in healthy participants: a randomized, placebo-controlled crossover trial.
Article References: Eikemo, M., Løseth, G.E., Carlyle, M. et al. Nat. Mental Health (2026). https://doi.org/10.1038/s44220-026-00700-x
DOI: https://doi.org/10.1038/s44220-026-00700-x
Image Credits: AI Generated
